Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by francois21on Oct 02, 2015 9:54am

193 Views

Post# 24156574

RE:RE:RE:RE:RE:Patients, Numbers and Meds

I only want to make the clarification on that part. The way it was written is not as clear as you just said it.

PLITheOne wrote:

If I may interject. PLI long was only stating that they would be recieving a treatment one way or the other. Sure there is a placebo however it is combined.